Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

CUSIP: 90400D108

Q2 2024 13F Holders as of 30 Jun 2024

Security identity
Security type / class
Equity / COMMON STOCK
Shares outstanding
98,459,627
Holder snapshot
Total 13F shares
88,212,580
Share change
+8,351,138
Total reported value
$3,625,598,894
Put/Call ratio
43%
Reported price per share
$41.10
Number of holders
273
Value change
+$337,028,289
Number of buys
161
Number of sells
119

Security key

90400D108

Report period

Q2 2024

Institutions

273

Top holders

10

RARE full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2024 Previous quarter: Q1 2024 Ultragenyx Pharmaceutical Inc. SEC filings Ultragenyx Pharmaceutical Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
VANGUARD GROUP INC
13D/G signal
—
Evidence rows
15
Latest as of
31 Mar 2024
13F Lead comparable stake: 8.8% Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
VANGUARD GROUP INC
13F
Company
13F
8.8%
$406,203,327
8,700,007 shares
 — 31 Mar 2024
RTW INVESTMENTS, LP
13F
Company
13F
7.2%
$330,897,399
7,087,115 shares
 — 31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
5.3%
$244,456,608
5,235,738 shares
 — 31 Mar 2024
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
13F
4.2%
$191,334,453
4,097,975 shares
 — 31 Mar 2024
SANDS CAPITAL MANAGEMENT, LLC
13F
Company
13F
3.9%
$180,197,580
3,859,447 shares
 — 31 Mar 2024
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
3.6%
$166,632,000
3,568,873 shares
 — 31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
273
Shares
88,212,580
Rows available
273
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
268
Q2 2024 holders
273
Holder diff
5
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .